Education
About Us
Working with TipRanks
Follow Us
Cresco Labs OTC (CRLBF)
:CRLBF
CRLBF Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRLBF Stock 12 Month Forecast
Average Price Target
$1.71
▲(90.00% Upside)
| Highest Price Target$2.00 | Average Price Target$1.71 | Lowest Price Target$1.42 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Roth MKM
$2
Buy
122.22%
Upside
Reiterated
11/06/25
Haywood
$1.43
Buy
58.35%
Upside
Reiterated
11/05/25
Cresco Labs: Strategic Market Focus and Financial Stability Justify Buy RatingCresco Labs reported Q3/25 financial results that were generally in line with expectations, with better-than-expected gross margins driving EBITDA slightly ahead of forecast. The Company continues to prioritize execution in core markets and balance sheet strength, highlighted by the successful refinancing of its senior credit facility and $6M in operating cash flow generated in the quarter. The completed exit from California simplifies Cresco’s footprint and removes low-margin operations, positioning the Company to focus on its strongest markets and margin expansion opportunities into 2026.
Beacon
$1.25
Buy
38.56%
Upside
Reiterated
08/18/25
Cresco Labs is still undervalued, this analyst saysBeacon Securities analyst Russell Stanley noted August 14 that Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) has completed its previously announced debt refinancing, closing on a five-year, $325-million senior secured term loan paying 12.5%.
Canaccord Genuity
$1.78→$1.07
Buy
18.76%
Upside
Reiterated
06/02/25
Cormark Securities
$1.25
Buy
38.56%
Upside
Upgraded
03/17/25
Alliance Global Partners
$2.49→$2.32
Buy
157.32%
Upside
Reiterated
03/12/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Roth MKM
$2
Buy
122.22%
Upside
Reiterated
11/06/25
Haywood
$1.43
Buy
58.35%
Upside
Reiterated
11/05/25
Cresco Labs: Strategic Market Focus and Financial Stability Justify Buy RatingCresco Labs reported Q3/25 financial results that were generally in line with expectations, with better-than-expected gross margins driving EBITDA slightly ahead of forecast. The Company continues to prioritize execution in core markets and balance sheet strength, highlighted by the successful refinancing of its senior credit facility and $6M in operating cash flow generated in the quarter. The completed exit from California simplifies Cresco’s footprint and removes low-margin operations, positioning the Company to focus on its strongest markets and margin expansion opportunities into 2026.
Beacon
$1.25
Buy
38.56%
Upside
Reiterated
08/18/25
Cresco Labs is still undervalued, this analyst saysBeacon Securities analyst Russell Stanley noted August 14 that Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) has completed its previously announced debt refinancing, closing on a five-year, $325-million senior secured term loan paying 12.5%.
Canaccord Genuity
$1.78→$1.07
Buy
18.76%
Upside
Reiterated
06/02/25
Cormark Securities
$1.25
Buy
38.56%
Upside
Upgraded
03/17/25
Alliance Global Partners
$2.49→$2.32
Buy
157.32%
Upside
Reiterated
03/12/25
Best Analysts Covering Cresco Labs
1 Month
xxx
Success Rate
7/12 ratings generated profit
Average Return
+3.33%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +3.33% per trade.
3 Months
xxx
Success Rate
5/15 ratings generated profit
Average Return
+5.31%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +5.31% per trade.
1 Year
Success Rate
5/12 ratings generated profit
Average Return
+42.34%
reiterated a buy rating 3 months ago
Copying Russell Stanley's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +42.34% per trade.
2 Years
xxx
Success Rate
10/12 ratings generated profit
Average Return
+27.49%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +27.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRLBF Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Nov 25
Strong Buy
3
3
3
6
5
Buy
0
0
0
0
0
Hold
9
11
14
17
17
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
14
17
23
22
Each month's total comprises the sum of three months' worth of ratings.
CRLBF Financial Forecast
CRLBF Stock Forecast FAQ
What is CRLBF’s average 12-month price target, according to analysts?
Based on analyst ratings, Cresco Labs OTC’s 12-month average price target is 1.71.
What is CRLBF’s upside potential, based on the analysts’ average price target?
Cresco Labs OTC has 90.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRLBF a Buy, Sell or Hold?
Cresco Labs OTC has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cresco Labs OTC’s price target?
The average price target for Cresco Labs OTC is 1.71. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $1.42. The average price target represents 90.00% Increase from the current price of $0.9.
The highest analyst price target is $2.00 ,the lowest forecast is $1.42. The average price target represents 90.00% Increase from the current price of $0.9.
What do analysts say about Cresco Labs OTC?
Cresco Labs OTC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of CRLBF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.